Pharmadons
ActiveSummary
Pharmadons has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €98,180 and a net result of -€9,746. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 27% of 12,578 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).
History
Acts, filings and financial milestones
23-07
Gazette deed
Appointment: BDM PHARMA SRL (director)Permanent representative: Mélissa DAMTCHOU MBITOM · Resignation: Stéphane LAMBERT (director)4 facts ▸
- General meeting, 01-07-2024
- Director appointment, BDM PHARMA SRL (director)
- Permanent representative, Mélissa DAMTCHOU MBITOM
- Director resignation, Stéphane LAMBERT (director)
19-06
Gazette deed
Resignation: LAMBERT Stéphane Urbain Henri (manager)Reappointment: LAMBERT Stéphane Urbain Henri (administrateurnonstatutaire) · Amendment of the articles · Capital conversion8 facts ▸
- General meeting, 09-01-2024
- Amendment of the articles (2 times)
- Capital conversion, “comptedecapitauxpropresstatutairementindisponible” (deed in French)
- Capital
- Director resignation, LAMBERT Stéphane Urbain Henri (manager)
- Director reappointment, LAMBERT Stéphane Urbain Henri (administrateurnonstatutaire)
- Other provision, “déchargeaugérantdémissionnaire, àdécider” (deed in French)
- Registered office clause, “1050Ixelles,FrançoisDonsstraat32” (deed in French)
Show earlier events
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.